Novavax vaccine demonstrates 89.3% efficacy
03 February, 2021Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.
Monash innovation reduces risk of COVID in healthcare workers
29 January, 2021A Monash University study reveals that a simple ventilated headboard hood can stop SARS-CoV-2 from spreading between patients and healthcare workers on hospital wards.
TGA approves Pfizer/BioNTech vaccine
25 January, 2021The Australian Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 mRNA vaccine, COMIRNATY.
GPs to take lead role in COVID-19 vaccine rollout
14 January, 2021The RACGP has welcomed government confirmation that GPs will be at the forefront of Australia's COVID-19 vaccine rollout.
Monash researchers outsmart superbug
13 January, 2021Researchers have discovered how to revert antibiotic resistance in one of the most dangerous superbugs: Acinetobacter baumannii — responsible for up to 20% of infections in ICUs.
Experts comment on early COVID vaccination rollout
08 January, 2021Australia's coronavirus vaccine rollout will be brought forward to next month, with Prime Minister Scott Morrison saying the first groups are expected to receive the jab in mid-to-late February.
Con-Serv Antimicrobial range
01 January, 2021Con-Serv has partnered with Biomaster to introduce a range of antimicrobial products, including showerheads, shower hoses, sliders and aerators.
Candida auris — a fungus with attitude
01 January, 2021Multidrug-resistant C. auris is an important emerging pathogen which demands attention and action when identified in the healthcare setting.
Vehicle partition screens: the PPE for healthcare rides
22 December, 2020 by Megan Whelan*Recent months have seen growing demand for partition screens in many countries to ensure extra precaution and mitigate the risks of coronavirus infection among drivers.
Isolation on demand, wherever you need it
17 December, 2020Clinell Rediroom is an innovative alternative to increase the availability of additional isolation space to help prevent infections and save lives.
Oxford publishes peer-reviewed COVID-19 vaccine results
16 December, 2020Interim results of the University of Oxford's COVID-19 vaccine Phase 3 trials find that the vaccine protects against symptomatic disease in 70% of cases on average.
Mobile CSSD provides flexible on-site capacity
15 December, 2020A mobile or modular on-site sterilisation department can ensure continuity during periods of refurbishment or exceptional demand.
UK hospitals deploy Aus-designed pop-up patient isolation rooms
08 December, 2020An instant patient isolation room that can be deployed in five minutes is being used by hospitals throughout the UK to isolate patients with COVID-19.
Research reveals gaps in adult pertussis vaccination
03 December, 2020Older Australians may be missing out on protection against pertussis because GPs tend to focus on vaccinating those in close contact with young children.
